Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
Introduction Inactivated vaccines were delivered to low- and middle-income countries during the early pandemics of COVID-19. Currently, more than 10 inactivated COVID-19 vaccines have been developed. Most inactivated vaccines contain an inactivated whole-cell index SARS-CoV-2 strain that is adjuvant...
| Main Authors: | , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Taylor & Francis Group
2024-12-01
|
| 叢編: | Expert Review of Vaccines |
| 主題: | |
| 在線閱讀: | https://www.tandfonline.com/doi/10.1080/14760584.2024.2320861 |